» Articles » PMID: 1885602

CCAAT Displacement Protein As a Repressor of the Myelomonocytic-specific Gp91-phox Gene Promoter

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1991 Sep 5
PMID 1885602
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

The cytochrome b heavy chain (gp91-phox) is expressed exclusively in terminally differentiating myelomonocytic cells. The human gp91-phox gene spans approximately 30 kilobases, and is divided into 13 exons. A ubiquitous factor that is indistinguishable from the CCAAT-binding factor CP1 interacts in vitro with the distal gp91-phox promoter CCAAT box motif. CP1 binding is prevented, however, by a CCAAT displacement protein (CDP) that binds to the region surrounding the CCAAT box. CDP DNA-binding activity is found in nuclear extracts prepared from cells in which the endogenous gp91-phox gene is transcriptionally inactive, but is absent or reduced in expressing cells, consistent with CDP functioning as a repressor of gp91-phox transcription. Introduction of gp91-phox promoter/reporter constructs into nonexpressing cells yields significantly less expression than that produced by the parental reporter vector alone. The reduction in expression is relieved when the CDP/CP1-binding site is removed from the gp91-phox promoter, confirming that it is a target for repression. No derepression is observed if the CP1-binding site is selectively mutated. Derepression of expression exhibited upon deletion of the CDP/CP1-binding site suggests that, in addition to blocking the interaction of the CCAAT-binding factor with the gp91-phox promoter, CDP may also repress transcription mediated through a distinct cis-element(s). We propose that down-regulation of CDP DNA-binding activity is a necessary step in the induction of myelomonocytic-specific expression of the gp91-phox gene.

Citing Articles

CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation.

Griesmann H, Muhl S, Riedel J, Theuerkorn K, Sipos B, Esposito I Cancers (Basel). 2021; 13(10).

PMID: 34070180 PMC: 8158495. DOI: 10.3390/cancers13102462.


CUX1, A Controversial Player in Tumor Development.

Liu N, Sun Q, Wan L, Wang X, Feng Y, Luo J Front Oncol. 2020; 10:738.

PMID: 32547943 PMC: 7272708. DOI: 10.3389/fonc.2020.00738.


The Hap Complex in Yeasts: Structure, Assembly Mode, and Gene Regulation.

Mao Y, Chen C Front Microbiol. 2019; 10:1645.

PMID: 31379791 PMC: 6652802. DOI: 10.3389/fmicb.2019.01645.


Distinct clinical and biological implications of in myeloid neoplasms.

Aly M, Ramdzan Z, Nagata Y, Balasubramanian S, Hosono N, Makishima H Blood Adv. 2019; 3(14):2164-2178.

PMID: 31320321 PMC: 6650742. DOI: 10.1182/bloodadvances.2018028423.


CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.

Ramdzan Z, Nepveu A Nat Rev Cancer. 2014; 14(10):673-82.

PMID: 25190083 DOI: 10.1038/nrc3805.